# Glucocorticoid Receptor Antagonism in Subclinical Cushings

> **NCT00721201** · PHASE1,PHASE2 · COMPLETED · sponsor: **Sheffield Teaching Hospitals NHS Foundation Trust** · enrollment: 6 (estimated)

## Conditions studied

- Subclinical Cushing's

## Interventions

- **DRUG:** Mifepristone

## Key facts

- **NCT ID:** NCT00721201
- **Lead sponsor:** Sheffield Teaching Hospitals NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2021-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00721201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00721201, "Glucocorticoid Receptor Antagonism in Subclinical Cushings". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00721201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*